Assignee
PDL BIOPHARMA INC
US·17 granted patents·9 pending applications·893 citations·filing 2000–2018
Top patents by PatentIndex Score
26 records- 0199US7217797B2Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesisPDL BIOPHARMA INC·Filed 2003·Granted May 15, 2007·298 cites·50 claims
- 0298US7217798B2Alteration of Fc-fusion protein serum half-lives by mutagenesisPDL BIOPHARMA INC·Filed 2004·Granted May 15, 2007·134 cites·15 claims
- 0397US7361740B2Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesisPDL BIOPHARMA INC·Filed 2004·Granted Apr 22, 2008·92 cites·16 claims
- 0496US7365168B2Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesisPDL BIOPHARMA INC·Filed 2005·Granted Apr 29, 2008·38 cites·8 claims
- 0595US7399469B2Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancerPDL BIOPHARMA INC·Filed 2005·Granted Jul 15, 2008·22 cites·10 claims
- 0695US7189507B2Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancerPDL BIOPHARMA INC·Filed 2002·Granted Mar 13, 2007·65 cites·13 claims
- 0793US7381803B1Humanized antibodies against CD3PDL BIOPHARMA INC·Filed 2000·Granted Jun 3, 2008·74 cites·9 claims
- 0893US7122185B2Anti-CCR5 antibodyPDL BIOPHARMA INC·Filed 2003·Granted Oct 17, 2006·50 cites·75 claims
- 0991US7435589B2Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancerPDL BIOPHARMA INC·Filed 2007·Granted Oct 14, 2008·15 cites·18 claims
- 1091US7288248B2Antibodies against cancer antigen TMEFF2 and uses thereofPDL BIOPHARMA INC·Filed 2003·Granted Oct 30, 2007·27 cites·7 claims
- 1188US7285268B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisPDL BIOPHARMA INC·Filed 2004·Granted Oct 23, 2007·18 cites·10 claims
- 1288US7276589B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisPDL BIOPHARMA INC·Filed 2003·Granted Oct 2, 2007·23 cites·9 claims
- 1384US7223393B2Amphiregulin antibodies and their use to treat cancer and psoriasisPDL BIOPHARMA INC·Filed 2004·Granted May 29, 2007·16 cites·6 claims
- 1482US7276372B2Antibodies against GPR64 and uses thereofPDL BIOPHARMA INC·Filed 2003·Granted Oct 2, 2007·12 cites·20 claims
- 1578US7183390B2Humanized antibodies to gamma-interferonPDL BIOPHARMA INC·Filed 2001·Granted Feb 27, 2007·9 cites·12 claims
- 1665US10716887B2Filtration modulePDL BIOPHARMA INC·Filed 2018·Granted Jul 21, 2020·0 cites·9 claims
- 1760US2008160018A1Humanized immunoglobulinsPDL BIOPHARMA INC·Filed 2006·Application pending·0 cites
- 1859US2008095768A1Use of allogeneic effector cells and anti-cs1 antibodies for selective killing of multiple myeloma cellsPDL BIOPHARMA INC·Filed 2007·Application pending·0 cites
- 1958US2008260740A1Anti-LFL2 Antibodies for the Diagnosis, Prognosis and Treatment of CancerPDL BIOPHARMA INC·Filed 2008·Application pending·0 cites
- 2055US2008226632A1Amphiregulin antibodies and their use to treat cancer and psoriasisPDL BIOPHARMA INC·Filed 2007·Application pending·0 cites
- 2155US2006286671A1Efficient generation of expression cell lines through the use of scorable homeostatic reporter genesPDL BIOPHARMA INC·Filed 2006·Application pending·0 cites
- 2252US10401368B2Antibodies and methods for the detection of cell deathPDL BIOPHARMA INC·Filed 2015·Granted Sep 3, 2019·0 cites·42 claims
- 2352US2007059748A1Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancerPDL BIOPHARMA INC·Filed 2006·Application pending·0 cites
- 2451US2008260730A1Treatment of Crohn's disease or psoriasis using anti-interferon gamma antibodiesPDL BIOPHARMA INC·Filed 2007·Application pending·0 cites
- 2548US2008181903A1Conjugate of natriuretic peptide and antibody constant regionPDL BIOPHARMA INC·Filed 2007·Application pending·0 cites
- 2643US2007224191A1Methods of treatment of Ulcerative Colitis and Crohn's disease with anti-CD3 antibodiesPDL BIOPHARMA INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PDL BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →